DJIA 17,356.87 0.00 0.00%
NASDAQ 4,644.31 0.00 0.00%
S&P 500 2,012.89 0.00 0.00%
market minute promo

Sarepta Therapeutics (NASDAQ: SRPT)

13.67 0.17 (1.26%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

SRPT $13.67 1.26%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $12.66
Previous Close $13.50
Daily Range $12.60 - $13.50
52-Week Range $12.58 - $40.00
Market Cap $564.7M
P/E Ratio -5.14
Dividend (Yield) $0.00 (0.0%)
Volume 1,116,415
Average Daily Volume 1,309,621
Current FY EPS -$3.19

Sector

Healthcare

Industry

Drugs

Sarepta Therapeutics (SRPT) Description

A biopharmaceutical company developing therapeutic products principally based on third-generation NEUGENE antisense technology. Website: http://www.sareptatherapeutics.com/

News & Commentary

Twitter's Favorite Biotech and Pharma Stocks

Consensus? We don't need no stinking consensus!

Does George Soros Think Biotech's Bull Run Is Finally Coming to an End?

The Soros Fund Managment sold off a number of biotechs in the third quarter. Do the actions of this closely watched fund signal that the industry's bull run is finally winding down?

Stocks Hitting 52-Week Lows

With Mid-2015 NDA Submission, Sarepta Can Rise

The 3 Most Memorable Moments in Healthcare This Year

Three Motley Fool analysts tell investors what they believe are the year's most memorable events in the healthcare sector.

Biotech Stock Mailbag: Aethlon Medical, Oxigene, Sarepta

Rolling with Biotech’s Regulatory Punches: Chen Lin

Health Care Sector Update for 11/26/2014: SRPT,RNA,BMRN,BDX,MRGE

Prosensa Soars on $680M Buyout Offer from BioMarin - Analyst Blog

Prosensa Soars on $680M Buyout Offer from BioMarin - Analyst Blog

Perilous Reversal Watch: Sarepta Therapeutics (SRPT)

See More SRPT News...

SRPT's Top Competitors

SRPT $13.67 (1.26%)
Current stock: SRPT
AMGN $166.06 (1.58%)
Current stock: AMGN
GILD $104.12 (1.68%)
Current stock: GILD
BIIB $338.01 (1.54%)
Current stock: BIIB